Update 10/08/2012 6:20 P.M.
The specialty pharmacy in Massachusetts which manufactured the injection drug used by back pain sufferers has now recalled it. but not before more than a hundred cases were reported in nine states, including Ohio.
Camden Clark Medical Center says it does not stock any of the steroid at its facilities. It is not affliated with the Pars Pain Center, which reported Friday it had stocked the product.
Memorial Health System, parent of Marietta Memorial and Selby Hospitals, has received calls as to whether it stocked it.
"Our pharmacy is on top of this," says Memorial Health Spokeswoman Jennifer Offenberger. "They are working with the appropriate organizations to monitor and to make sure we are not acquiring and using that injection."
The location of the Ohio case has not been made public. But health officials say none of the ohio clinics which use the drug is in our area.
UPDATE: 10/6/2012 6:50 PM
The Centers for Disease Control and Prevention reports one case has been found in Ohio.
Ohio's Health Department confirms there's one case in the state.
The outbreak has been linked to a steroid produced by a specialty pharmacy in Massachusetts.
Health officials say four Ohio health care facilities used the steroid.
Those clinics are in Cincinnati, Marion and the Columbus suburb of Dublin.
More than 60 people in 9 states have been affected. Federal officials say seven people have died nationwide from the outbreak.
From the Mid-Ohio Valley Health Department:
For Immediate Release-October 5, 2012
The Centers for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA) are coordinating a multi-state investigation of fungal meningitis among patients who received an epidural steroid injection. As of October 5, 2012, forty-seven cases and five deaths in seven states have been reported. Investigation into the exact source is ongoing; however, preliminary data suggest that all infected patients received injection with preservative-free methylprednisolone acetate prepared by New England Compounding Center, located in Framingham, MA. That medication has been recalled and FDA has documented fungal contamination in a sealed vial taken from the manufacturer.
The PARS Pain Center in Parkersburg, WV was one of many clinics in 23 states that received the recalled medication. Health officials are working with the clinic to rapidly notify all patients who are at risk. Some patients that received steroid injections between August 6 and September 25, 2012 at PARS Pain Center may have received medication from these recalled lots. Only those PARS patients receiving steroids between August 6 and September 25 are considered to be at risk. As of October 5, there have been no reports of meningitis associated with this clinic.
Fungal meningitis is not transmitted from person to person. Symptoms of fungal meningitis emerge approximately 1 to 4 weeks following the steroid injection, including: fever, neck stiffness, light sensitivity, new or worsening headache, nausea, and new neurological deficit (consistent with deep brain stroke). The CDC and the FDA have recommended that healthcare professionals cease use of ANY product produced by the New England Compounding Center until further notice. At this time infections have only been found in patients who have received epidural steroid injections, however, all patients who received injections with recalled medication will be contacted and encouraged to seek evaluation if they develop symptoms. Patients at risk who develop symptoms consistent with meningitis should contact their physician immediately.